Prognostic score and cytogenetic risk classification for chronic lymphocytic leukemia patients: Center for International blood and marrow transplant research report Academic Article uri icon

Overview

MeSH Major

  • Depression
  • Depressive Disorder
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes

abstract

  • In this large cohort of patients with previously treated CLL who underwent RIC HCT, we developed a robust prognostic scoring system of HCT outcomes and a novel cytogenetic-based risk stratification system. These prognostic models can be used for counseling patients, comparing data across studies, and providing a benchmark for future interventions. For future study, we will further validate these models for patients receiving targeted therapies prior to HCT.

authors

publication date

  • August 15, 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC6697588

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-18-3988

PubMed ID

  • 31253630

Additional Document Info

start page

  • 5143

end page

  • 5155

volume

  • 25

number

  • 16